Status: ceased operations; technology acquired and shelved
VisiGen was developing a single molecule sequencer when they were acquired by Life Technologies (Invitrogen) in 2008 for $20M. The technology, now known by the codename ‘Starlight’, has been deprioritized due to the focus on the SOLiD and Ion Torrent technologies. In a recent court filing in the IP lawsuit brought by Helicos, Life Technologies went so far as to say they have no plans to commercialize it in the future.
Please contact us at firstname.lastname@example.org if you have any information or opinions you’d like to share about this page.